Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1993 May 1;291(Pt 3):875–881. doi: 10.1042/bj2910875

Identification of a receptor for ADP on blood platelets by photoaffinity labelling.

G Cristalli 1, D C Mills 1
PMCID: PMC1132450  PMID: 8387782

Abstract

The synthesis of a new analogue of ADP, 2-(p-azidophenyl)-ethythioadenosine 5'-diphosphate (AzPET-ADP), is described. This compound contains a photolabile phenylazide group attached to the ADP molecule by a thioether link at the purine 2 position. It has been prepared in radioactive form with 32P in the beta-phosphate at a specific radioactivity of 100 mCi/mumol. The reagent activated platelets, causing shape change and aggregation, with somewhat lower affinity than ADP. On photolysis the affinity was increased. The reagent also inhibited platelet adenylate cyclase stimulation by prostaglandin E1, with considerably higher affinity than ADP. On photolysis the affinity was decreased. AzPET-ADP competitively inhibited the binding of 2-methylthio[beta-32P]ADP, a ligand for the receptor by which ADP causes inhibition of adenylate cyclase. In the dark, AzPET-[beta-32P]ADP bound reversibly and with high affinity to a single population of sites similar in number to the sites that bind 2-methylthio[beta-32P]ADP. Binding was inhibited by ADP and by ATP and by p-chloromercuribenzenesulphonic acid (pCMBS). On exposure to u.v. light in the presence of platelets, AzPET-[beta-32P]ADP was incorporated covalently but non-specifically into several platelet proteins, although prominent intracellular proteins were not labelled. Specific labelling was confined to a single region of SDS/polyacrylamide gels, overlying but not comigrating with actin. Incorporation of radioactivity into this region was inhibited by ADP and by ATP as well as by ADP beta S, ATP alpha S and pCMBS, but not by adenosine, GDP or AMP. Inhibition of AzPET-[beta-32P]ADP incorporation was closely correlated with inhibition of equilibrium binding of 2-methylthio[beta-32P]ADP. These results suggests that the labelled protein, which migrates with an apparent molecular mass of 43 kDa in reduced gels, is the receptor through which ADP inhibits adenylate cyclase.

Full text

PDF
877

Images in this article

879Figure 5
on p.879

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BORN G. V. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962 Jun 9;194:927–929. doi: 10.1038/194927b0. [DOI] [PubMed] [Google Scholar]
  2. Colman R. W. Aggregin: a platelet ADP receptor that mediates activation. FASEB J. 1990 Mar;4(5):1425–1435. doi: 10.1096/fasebj.4.5.2407587. [DOI] [PubMed] [Google Scholar]
  3. Cusack N. J., Born G. V. Effects of photolysable 2-azido analogues of adenosine, AMP and ADP on human platelets. Proc R Soc Lond B Biol Sci. 1977 Jul 20;197(1129):515–520. doi: 10.1098/rspb.1977.0084. [DOI] [PubMed] [Google Scholar]
  4. Cusack N. J., Hourani S. M. Adenosine 5-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors. Br J Pharmacol. 1982 May;76(1):221–227. doi: 10.1111/j.1476-5381.1982.tb09210.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cusack N. J., Hourani S. M. Effects of RP and SP diastereoisomers of adenosine 5'-O-(1-thiodiphosphate) on human platelets. Br J Pharmacol. 1981 Jun;73(2):409–412. doi: 10.1111/j.1476-5381.1981.tb10437.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. GAARDER A., JONSEN J., LALAND S., HELLEM A., OWREN P. A. Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature. 1961 Nov 11;192:531–532. doi: 10.1038/192531a0. [DOI] [PubMed] [Google Scholar]
  7. Gough G., Maguire M. H., Penglis F. Analogues of adenosine 5'-diphosphate-new platelet aggregators. Influence of purine ring and and phosphate chain substitutions on the platelet-aggregating potency of adenosine 5'-diphosphate. Mol Pharmacol. 1972 Mar;8(2):170–177. [PubMed] [Google Scholar]
  8. Greco N. J., Yamamoto N., Jackson B. W., Tandon N. N., Moos M., Jr, Jamieson G. A. Identification of a nucleotide-binding site on glycoprotein IIb. Relationship to ADP-induced platelet activation. J Biol Chem. 1991 Jul 25;266(21):13627–13633. [PubMed] [Google Scholar]
  9. HOARD D. E., OTT D. G. CONVERSION OF MONO- AND OLIGODEOXYRIBONUCLEOTIDES TO 5-TRIPHOSPHATES. J Am Chem Soc. 1965 Apr 20;87:1785–1788. doi: 10.1021/ja01086a031. [DOI] [PubMed] [Google Scholar]
  10. Haslam R. J., Davidson M. M., Desjardins J. V. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP. Biochem J. 1978 Oct 15;176(1):83–95. doi: 10.1042/bj1760083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Haslam R. J., McClenaghan M. D. Measurement of circulating prostacyclin. Nature. 1981 Jul 23;292(5821):364–366. doi: 10.1038/292364a0. [DOI] [PubMed] [Google Scholar]
  12. Hourani S. M., Cusack N. J. Pharmacological receptors on blood platelets. Pharmacol Rev. 1991 Sep;43(3):243–298. [PubMed] [Google Scholar]
  13. Jefferson J. R., Harmon J. T., Jamieson G. A. Identification of high-affinity (Kd 0.35 mumol/L) and low-affinity (Kd 7.9 mumol/L) platelet binding sites for ADP and competition by ADP analogues. Blood. 1988 Jan;71(1):110–116. [PubMed] [Google Scholar]
  14. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  15. Macfarlane D. E., Mills D. C. Inhibition by ADP of prostaglandin induced accumulation of cyclic AMP in intact human platelets. J Cyclic Nucleotide Res. 1981;7(1):1–11. [PubMed] [Google Scholar]
  16. Macfarlane D. E., Mills D. C., Srivastava P. C. Binding of 2-azidoadenosine [beta-32P]diphosphate to the receptor on intact human blood platelets which inhibits adenylate cyclase. Biochemistry. 1982 Feb 2;21(3):544–549. doi: 10.1021/bi00532a020. [DOI] [PubMed] [Google Scholar]
  17. Macfarlane D. E., Mills D. C. The effects of ATP on platelets: evidence against the central role of released ADP in primary aggregation. Blood. 1975 Sep;46(3):309–320. [PubMed] [Google Scholar]
  18. Macfarlane D. E., Srivastava P. C., Mills D. C. 2-Methylthioadenosine[beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets. J Clin Invest. 1983 Mar;71(3):420–428. doi: 10.1172/JCI110786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Maguire M. H., Michal F. Powerful new aggregator of blood platelets--2-chloroadenosine-5'-diphosphate. Nature. 1968 Feb 10;217(5128):571–573. doi: 10.1038/217571a0. [DOI] [PubMed] [Google Scholar]
  20. Mills D. C., Figures W. R., Scearce L. M., Stewart G. J., Colman R. F., Colman R. W. Two mechanisms for inhibition of ADP-induced platelet shape change by 5'-p-fluorosulfonylbenzoyladenosine. Conversion to adenosine, and covalent modification at an ADP binding site distinct from that which inhibits adenylate cyclase. J Biol Chem. 1985 Jul 5;260(13):8078–8083. [PubMed] [Google Scholar]
  21. Mills D. C., Puri R., Hu C. J., Minniti C., Grana G., Freedman M. D., Colman R. F., Colman R. W. Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase. Arterioscler Thromb. 1992 Apr;12(4):430–436. doi: 10.1161/01.atv.12.4.430. [DOI] [PubMed] [Google Scholar]
  22. O'brien J. R. Platelet aggregation: Part I Some effects of the adenosine phosphates, thrombin, and cocaine upon platelet adhesiveness. J Clin Pathol. 1962 Sep;15(5):446–452. doi: 10.1136/jcp.15.5.446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Powling M. J., Hardisty R. M. Glycoprotein IIb-IIIa complex and Ca2+ influx into stimulated platelets. Blood. 1985 Sep;66(3):731–734. [PubMed] [Google Scholar]
  24. Robey F. A., Jamieson G. A., Hunt J. B. Synthesis and use of a new spin-labeled analogue of ADP with platelet-aggregating activity. J Biol Chem. 1979 Feb 25;254(4):1114–1118. [PubMed] [Google Scholar]
  25. Salzman E. W. Cyclic AMP and platelet function. N Engl J Med. 1972 Feb 17;286(7):358–363. doi: 10.1056/NEJM197202172860708. [DOI] [PubMed] [Google Scholar]
  26. Vassallo R. R., Jr, Kieber-Emmons T., Cichowski K., Brass L. F. Structure-function relationships in the activation of platelet thrombin receptors by receptor-derived peptides. J Biol Chem. 1992 Mar 25;267(9):6081–6085. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES